Israeli biomed startup Omeq Medical, which is developing a sensor-based solution to reduce the pain involved in epidural injection, has received a NIS 2.5 million (approx. $700,000) injection.
The injection was given by Omeq Medical’s parent accelerator Misgav, a part of the TrendLines Group.
Related posts
Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023
Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023
ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments